TELA Bio, Inc. TELA 深 沪
已收盘 02-13 16:00:00 美东时间
0.7709
-0.015
-1.90%
华盛通- 最 高1.195
- 今 开0.78
- 成交量 2.45万股
- 最 低 0.6759
- 昨 收 0.7858
- 总市值 1.12万
- 52周最高 2.73
- 市盈率 静 --
- 换手率 167.97%
- 52周最低 0.6759
- 委 比 98.39%
- 总股本 1.46万
- 历史最高 23.545
- 量 比 0.19
- 振 幅 66.06%
- 历史最低 0.6759
- 每 手 1
- 风险率 0.48%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Small Medtech TELA Bio Takes On Becton Dickinson, Alleges Hernia Mesh Monopoly
TELA Bio is suing Becton Dickinson for allegedly abusing its monopoly power in the hernia mesh market to limit competition and harm patients.
2025-12-23 21:48
TELA Bio Prices ~$13M Common Stock, Pre-Funded Offering
TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the pricing of an underwritten registered direct offering of
2025-11-14 05:23
Earnings Scheduled For November 13, 2025
Companies Reporting Before The Bell • Edgewell Personal Care (NYSE:EPC) is proj...
2025-11-13 19:11
国联民生证券-医药生物行业AI医疗海外跟踪：癌症早筛、脑机接口、AI制药取得突破性进展-250716
（来源：研报虎） 全球AI医疗投融资火热 2025年6月全球AI医疗投融资项目中融资金额过亿美元有4个，其中包括人工智能医疗应用程序开发商Abridge获...
2025-07-16 16:07
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
TELA Bio granted Jim Hagen, its Senior Vice President, 75,000 stock options and 30,000 restricted stock units as part of his employment inducement package. The options have an exercise price of $1.42 per share, vest over four years, and expire in ten years. The RSUs vest annually over four years.
2025-06-06 20:05
TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair
TELA Bio宣布在欧洲推出专为腹股沟疝修补设计的OviTex Inguinal生物补片，该产品为微创及机器人手术而优化，已在2024年在美国上市并取得超过100万美元的销售额。
2025-06-03 20:05
TELA Bio Appoints Jeffrey Blizard as President
TELA Bio强化领导团队，任命Jeffrey Blizard为总裁，以推动增长和加强市场竞争力。
2025-06-02 12:30
TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference
TELA Bio, Inc. will present at the 2025 Jefferies Global Healthcare Conference on June 5, 2025. The presentation will be available live and archived at ir.telabio.com.
2025-05-22 20:05
